IL Receptor
Interleukin receptors (IL receptors) are a group of receptors that bind to interleukins, a family of cytokines that play essential roles in immune system regulation, inflammation, and hematopoiesis. Dysregulation of interleukin signaling is associated with various inflammatory and autoimmune diseases, making IL receptors critical targets for therapeutic intervention. IL receptor antagonists are being explored for the treatment of conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. At CymitQuimica, we offer a range of high-quality IL receptor modulators to support your research in cytokine signaling, immunology, and inflammatory disease therapy.
Found 74 products of "IL Receptor"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Vunakizumab
CAS:Vunakizumab is a humanized IgGκ monoclonal antibody targeting IL-17A, often linked to interleukin 22 to form Vunakizumab-IL22.Purity:95%Color and Shape:LiquidMolecular weight:146.38 kDaBermekimab
CAS:Bermekimab (MABp1), an anti-interleukin-1α (IL-1α) monoclonal antibody.Bermekimab has potential anti-inflammatory activity to prevent skin inflammation.Color and Shape:LiquidMolecular weight:145.45 kDaYQ128
CAS:YQ128 is a potent and selective inhibitor of second-generation NLRP3 (NOD-like receptor P3) inflammasome(IC50 of 0.30 µM), with anti-inflammatory activity.Formula:C27H29ClN2O4S2Purity:99.89%Color and Shape:SolidMolecular weight:545.11Ref: TM-T13375
1mg52.00€5mg113.00€10mg177.00€25mg289.00€50mg485.00€100mg700.00€1mL*10mM (DMSO)137.00€PF-07038124 HCl
CAS:PF-07038124 HCl is a selective and potent PDE4 inhibitor with an IC50 of 0.5 nM for PDE4B2.PF-07038124 HCl inhibits IL-13, IL-4, and IFNγ, and can be used in the study of skin disorders such as atopic dermatitis and plaque psoriasis.Formula:C18H23BClNO4Purity:97.34% - 99.13%Color and Shape:SoildMolecular weight:363.64Nidanilimab
CAS:Nidanilimab (CAN04) is an IL1RAP antibody with 1.10 pM affinity and antitumor effects on NSCLC and PDAC.
Purity:> 95%Color and Shape:SoildMolecular weight:150 kDaSpesolimab
CAS:Spesolimab (BI 655130) is an antibody targeting IL-36 receptor, key in immunity, for systemic pustular psoriasis and dermatitis studies.Purity:> 95%Color and Shape:LiquidMolecular weight:150 kDaSarilumab
CAS:Sarilumab: Potent IL-6 blocker, human antibody, reduces inflammation, treats rheumatoid arthritis.Purity:97.4%Color and Shape:LiquidMolecular weight:144.12 kDaIxekizumab
CAS:Ixekizumab: IgG4 antibody, neutralizes IL-17A (<3 pM), treats severe plaque psoriasis & arthritis.Purity:98.86% (SEC-HPLC) - > 99.3% (SDS-PAGE); 95.4% (SEC-HPLC)Color and Shape:LiquidMolecular weight:146.2 kDaIL-15-IN-1
CAS:IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).Formula:C30H36N6O4SPurity:99.16%Color and Shape:SolidMolecular weight:576.71Ref: TM-T11634
1mg88.00€5mg170.00€10mg259.00€25mg429.00€50mg605.00€100mg815.00€200mg1,093.00€1mL*10mM (DMSO)210.00€2-Benzothiazolamine
CAS:2-ABT: nitrogen-rich heterocycle used in drug synthesis, inhibits P450, with anti-inflammatory, anticonvulsant, anticancer properties.Formula:C7H6N2SPurity:99.09% - 99.3%Color and Shape:Plates From Water Physical Description Odorless Gray To White Powder (Ntp 1992)Molecular weight:150.2Siltuximab
CAS:Siltuximab（CNTO-328） is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19.Purity:100% (SEC-HPLC) - > 95%Color and Shape:LiquidMolecular weight:144.98 kDaEnokizumab
CAS:Enokizumab (MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma.
Purity:SDS-PAGE:95% SEC-HPLC:99.23%Color and Shape:LiquidMolecular weight:145.98 kDaRisankizumab
CAS:Risankizumab (BI 655066) is a monoclonal antibody for psoriasis, targeting IL-23, with high affinity (Kd <10 pM) and an IC50 of 2 pM.Purity:SDS-PAGE:95.3%;SEC-HPLC:98.3%Color and Shape:LiquidMolecular weight:145.85 kDaOrdesekimab
CAS:Ordesekimab (AMG 714) is a human anti-IL-15 IgG1 κ monoclonal antibody for studying NRCD.Purity:> 95%Color and Shape:LiquidMolecular weight:145.12 kDaTildrakizumab
CAS:Tildrakizumab (SCH 900222) is a humanized antibody against IL-23, with a 136 pM Kd, used for psoriasis research.Purity:> 95%Color and Shape:LiquidMolecular weight:144.44 kDaBrodalumab
CAS:Brodalumab (AMG 827), a human IgG2 monoclonal antibody, inhibits IL-17R, treating psoriasis.Purity:98.3%Color and Shape:LiquidMolecular weight:144.06 kDaDaclizumab
CAS:Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.Purity:SDS-PAGE:95% SEC-HPLC:99.99%Color and Shape:LiquidMolecular weight:144.12 kDaNosantine racemate
CAS:Nosantine racemate is the racemate of Nosantine which is a IL-2 inducer or enhancer of IL-2 induction by phytohemagglutinin (PHA).Formula:C14H22N4O2Purity:98%Color and Shape:SolidMolecular weight:278.35Canakinumab
CAS:Canakinumab: Human IL-1β antibody, anti-inflammatory, treats gout & coronary disease, IC50 of 43.6 pM (human), 40.8 pM (monkey).
Purity:98.8%Color and Shape:LiquidMolecular weight:145.18 kDaTorudokimab
Torudokimab (ZB-880) is a monoclonal antibody that neutralizes interleukin 33 and can be used to study immune system diseases.Purity:95.8% (SDS-PAGE); 96.2% (SEC-HPLC) - 95.8% (SDS-PAGE); 96.2% (SEC-HPLC)Color and Shape:LiquidMolecular weight:144.71 kDa
